These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31367740)

  • 1. An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline Antibiotic.
    Opal S; File TM; van der Poll T; Tzanis E; Chitra S; McGovern PC
    Clin Infect Dis; 2019 Aug; 69(Suppl 1):S40-S47. PubMed ID: 31367740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
    Zhanel GG; Esquivel J; Zelenitsky S; Lawrence CK; Adam HJ; Golden A; Hink R; Berry L; Schweizer F; Zhanel MA; Bay D; Lagacé-Wiens PRS; Walkty AJ; Lynch JP; Karlowsky JA
    Drugs; 2020 Feb; 80(3):285-313. PubMed ID: 31970713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omadacycline: A Modernized Tetracycline.
    Gallagher JC
    Clin Infect Dis; 2019 Aug; 69(Suppl 1):S1-S5. PubMed ID: 31367739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omadacycline for Community-Acquired Bacterial Pneumonia.
    Stets R; Popescu M; Gonong JR; Mitha I; Nseir W; Madej A; Kirsch C; Das AF; Garrity-Ryan L; Steenbergen JN; Manley A; Eckburg PB; Tzanis E; McGovern PC; Loh E
    N Engl J Med; 2019 Feb; 380(6):517-527. PubMed ID: 30726692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of omadacycline for treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in patients with mild-to-moderate renal impairment.
    Cornely OA; File TM; Garrity-Ryan L; Chitra S; Noble R; McGovern PC
    Int J Antimicrob Agents; 2021 Feb; 57(2):106263. PubMed ID: 33326848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omadacycline (Nuzyra)--a new tetracycline antibiotic.
    Med Lett Drugs Ther; 2019 May; 61(1572):74-77. PubMed ID: 31169800
    [No Abstract]   [Full Text] [Related]  

  • 7. Omadacycline: a therapeutic review of use in community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
    Chopra T; Sandhu A; Theriault N; Meehan J; Tillotson G
    Future Microbiol; 2020 Sep; 15():1319-1333. PubMed ID: 32959689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omadacycline for Acute Bacterial Skin and Skin-Structure Infections.
    O'Riordan W; Green S; Overcash JS; Puljiz I; Metallidis S; Gardovskis J; Garrity-Ryan L; Das AF; Tzanis E; Eckburg PB; Manley A; Villano SA; Steenbergen JN; Loh E
    N Engl J Med; 2019 Feb; 380(6):528-538. PubMed ID: 30726689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections.
    Villano S; Steenbergen J; Loh E
    Future Microbiol; 2016 Oct; 11():1421-1434. PubMed ID: 27539442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial.
    O'Riordan W; Cardenas C; Shin E; Sirbu A; Garrity-Ryan L; Das AF; Eckburg PB; Manley A; Steenbergen JN; Tzanis E; McGovern PC; Loh E;
    Lancet Infect Dis; 2019 Oct; 19(10):1080-1090. PubMed ID: 31474458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omadacycline: A New Tetracycline Antibiotic.
    Dougherty JA; Sucher AJ; Chahine EB; Shihadeh KC
    Ann Pharmacother; 2019 May; 53(5):486-500. PubMed ID: 30917674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omadacycline: First Global Approval.
    Markham A; Keam SJ
    Drugs; 2018 Dec; 78(18):1931-1937. PubMed ID: 30471003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Return of the tetracyclines: omadacycline, a novel aminomethylcycline antimicrobial.
    Cho JC; Childs-Kean LM; Zmarlicka MT; Crotty MP
    Drugs Today (Barc); 2018 Mar; 54(3):209-217. PubMed ID: 29771255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omadacycline in Skin Infections and Pneumonia: A Review of the Evidence.
    Vacalis S; Brunton S; Gindi J
    J Fam Pract; 2022 Jun; 71(5 Suppl):S10-S21. PubMed ID: 35776862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omadacycline in treating community-based infections: a review and expert perspective.
    Sakoulas G; Nowak M; Geriak M
    Expert Rev Anti Infect Ther; 2023 Mar; 21(3):255-265. PubMed ID: 36718489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omadacycline vs moxifloxacin in adults with community-acquired bacterial pneumonia.
    Torres A; Garrity-Ryan L; Kirsch C; Steenbergen JN; Eckburg PB; Das AF; Curran M; Manley A; Tzanis E; McGovern PC
    Int J Infect Dis; 2021 Mar; 104():501-509. PubMed ID: 33484864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omadacycline for Acute Bacterial Skin and Skin Structure Infections.
    Abrahamian FM; Sakoulas G; Tzanis E; Manley A; Steenbergen J; Das AF; Eckburg PB; McGovern PC
    Clin Infect Dis; 2019 Aug; 69(Suppl 1):S23-S32. PubMed ID: 31367742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omadacycline: A Novel Tetracycline Derivative With Oral and Intravenous Formulations.
    Watkins RR; Deresinski S
    Clin Infect Dis; 2019 Aug; 69(5):890-896. PubMed ID: 30893428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic.
    Tanaka SK; Steenbergen J; Villano S
    Bioorg Med Chem; 2016 Dec; 24(24):6409-6419. PubMed ID: 27469981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision Analysis: Omadacycline Relative to Moxifloxacin Among Hospitalized Community-Acquired Bacterial Pneumonia Patients at Risk of Clostridioides difficile Infection.
    Lodise TP; Mistry R; Young K; LaPensee K
    Clin Drug Investig; 2021 Mar; 41(3):269-275. PubMed ID: 33604769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.